Medical News (via PRIMEZONE)
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
3423 records returned
Intuitive Surgical Announces Transition of Gary Guthart to CEO
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SUNNYVALE, Calif., Oct. 23, 2009 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), the industry leader in surgical robotics, today announced the next step in its CEO succession plan. Lonnie Smith, currently Chairman and CEO, will transition to the role of Chairman of the Board and Gary Guthart, currently President and Chief Operating Officer, has been appointed by the Board of Directors to the roles of President and CEO, both actions effective January 1, 2010.
Source: Medical News (via PRIMEZONE) - October 23, 2009 Category: Pharmaceuticals Source Type: news
Memorial Hermann's Memorial Family Medicine Residency and Physicians at Sugar Creek Awarded Medical Home DesignationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HOUSTON, Oct. 23, 2009 (GLOBE NEWSWIRE) -- The National Committee for Quality Assurance (NCQA) has designated Memorial Hermann's Memorial Family Medicine Residency and its medical office, the Physicians at Sugar Creek, as a Recognized Medical Home. They are the only residency program and medical practice in Texas to receive this designation.
Source: Medical News (via PRIMEZONE) - October 23, 2009 Category: Pharmaceuticals Source Type: news
Capstone Therapeutics to Present at 4th Annual BIOCOM Investor ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TEMPE, Ariz., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) is scheduled to make a presentation at the BIOCOM Investor Conference, Hyatt Regency La Jolla (CA) on October 26, 2009 at 3:30pm PDT. Dana B. Shinbaum, Vice President, Business Development will provide an overview and discuss the Company's current operating environment and business strategy.
Source: Medical News (via PRIMEZONE) - October 22, 2009 Category: Pharmaceuticals Source Type: news
Questcor Implements Two Corporate Governance ActionsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
UNION CITY, Calif., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) today announced that its Board of Directors has unanimously approved two corporate governance matters to provide Questcor's shareholders more say with respect to proposals to acquire the Company and better information about the economic interests of proponents of shareholder proposals and director nominations.
Source: Medical News (via PRIMEZONE) - October 22, 2009 Category: Pharmaceuticals Source Type: news
NightHawk Radiology Holdings, Inc. to Host Conference Call to Discuss Third Quarter 2009 Earnings ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
COEUR D'ALENE, Idaho, Oct. 22, 2009 (GLOBE NEWSWIRE) -- NightHawk Radiology Holdings, Inc. (Nasdaq:NHWK), the leading provider of radiology solutions to radiology groups and hospitals throughout the United States, today announced that it will host a conference call on Thursday, November 5, 2009 at 4:30 p.m. eastern time with management to review the Company's third quarter 2009 earnings results.
Source: Medical News (via PRIMEZONE) - October 22, 2009 Category: Pharmaceuticals Source Type: news
OraSure Technologies Earnings Conference Call InvitationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BETHLEHEM, Pa., Oct. 22, 2009 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) has scheduled its regular earnings conference call covering 2009 third quarter financial results and certain 2009 financial guidance for 5:00 p.m. ET (2:00 p.m. PT) on Wednesday, November 4, 2009. An update on certain business developments will also be provided.
Source: Medical News (via PRIMEZONE) - October 22, 2009 Category: Pharmaceuticals Source Type: news
Entra Health Provides Diabetic Testing Support for the Black Barbershop Health Outreach ProgramEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN DIEGO, Oct. 22, 2009 (GLOBE NEWSWIRE) -- Entra Health Systems, an international applied healthcare technology company, today announced support for the Black Barbershop Health Outreach Program in their mission to increase public awareness of diabetes and its complications through early detection, information dissemination, and referral to appropriate medical resources. Entra Health will supply the program with the new MyGlucoHealth blood glucose meter and test strips for its upcoming one-day screenings in Los Angeles.
Source: Medical News (via PRIMEZONE) - October 22, 2009 Category: Pharmaceuticals Source Type: news
HealthTronics Third Quarter Conference Call to Take Place On November 5, 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AUSTIN, Texas, Oct. 22, 2009 (GLOBE NEWSWIRE) -- HealthTronics, Inc. (Nasdaq:HTRN), will issue its financial results for the third quarter ended September 30, 2009 on Thursday, November 5, 2009 after the stock market closes. HealthTronics will then conduct a conference call to discuss these results and other business activities at HealthTronics with President and Chief Executive Officer James Whittenburg and interim Chief Financial Officer Richard Rusk at 5:00 pm EST.
Source: Medical News (via PRIMEZONE) - October 22, 2009 Category: Pharmaceuticals Source Type: news
Utah Medical Products, Inc. Reports Financial Performance for Third Quarter 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SALT LAKE CITY, Oct. 22, 2009 (GLOBE NEWSWIRE) -- In the third calendar quarter (3Q) 2009 and three quarters year-to-date, or nine months (9M) of 2009, Utah Medical Products, Inc.'s (Nasdaq:UTMD) changes in financial results compared to the same time period in the prior calendar year were as follows:
Source: Medical News (via PRIMEZONE) - October 22, 2009 Category: Pharmaceuticals Source Type: news
Competitive Technologies' Pain Therapy Medical Device to Treat Patients at University of Wisconsin-MadisonEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FAIRFIELD, Conn., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (NYSE Amex:CTT) announced today that the University of Wisconsin-Madison will use CTT's pain therapy medical device to treat patients at its Carbone Cancer Center in the School of Medicine and Public Health, under the direction of Toby C. Campbell, M.D., Miroslav "Misha" Backonja, M.D., and James Cleary, M.D. Drs. Cleary and Campbell are national leaders in palliative care at the University of Wisconsin Carbone Cancer Center. Dr. Backonja is recognized as a global authority in neuropathic pain treatment and is Professor of Neurology at the U...
Source: Medical News (via PRIMEZONE) - October 22, 2009 Category: Pharmaceuticals Source Type: news
Today's Ingen CEO Live Interview With The Money ChannelEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
YUCAIPA, Calif., Oct. 22, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries announced today that the CEO, Scott Sand, will present the Sales and Marketing program for the new Oxyview Nasal Cannula on the live broadcast of The Money Channel's American Scene Radio scheduled later today at 11:34 AM eastern standard time.
Source: Medical News (via PRIMEZONE) - October 22, 2009 Category: Pharmaceuticals Source Type: news
IRIS to Present at Oppenheimer 20th Annual Healthcare Conference in New York, November 3, 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CHATSWORTH, Calif., Oct. 22, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, today announced that Chief Financial Officer, Peter L. Donato, will present an overview of the Company at The Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3, 2009, at 1:00 p.m. Eastern time at the Waldorf Astoria Hotel in New York City.
Source: Medical News (via PRIMEZONE) - October 22, 2009 Category: Pharmaceuticals Source Type: news
Rescare Acquires New Jersey Home Care BusinessEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LOUISVILLE, Ky., Oct. 22, 2009 (GLOBE NEWSWIRE) -- ResCare, Inc. (Nasdaq:RSCR), the nation's leading provider of residential, training, education, workforce and support services for people with special needs, today announced that it has acquired the assets of All Quality Care, a Newton, New Jersey, home care agency providing hourly nursing and aide services, case management, wound care, pediatric and IV therapy as well as other services to assist people in their homes. All Quality Care serves approximately 220 people in 10 counties including Sussex, Hunterdon, Warren and Essex. Annual revenues are expected to be approximat...
Source: Medical News (via PRIMEZONE) - October 22, 2009 Category: Pharmaceuticals Source Type: news
ResCare, Inc. to Webcast Its Third Quarter 2009 Earnings Conference Call on November 6, 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LOUISVILLE, Ky., Oct. 21, 2009 (GLOBE NEWSWIRE) -- ResCare (Nasdaq:RSCR) today announced that it will provide an online, real-time webcast and rebroadcast of its third quarter 2009 earnings conference call on Friday, November 6, 2009. The Company will release its results for the third quarter and nine months ended September 30, 2009, after the close of market on Thursday, November 5, 2009.
Source: Medical News (via PRIMEZONE) - October 21, 2009 Category: Pharmaceuticals Source Type: news
SenoRx Ranked Among the Fastest Growing Companies in North America on Deloitte's 2009 Technology Fast 500Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
IRVINE, Calif., Oct. 21, 2009 (GLOBE NEWSWIRE) -- SenoRx (Nasdaq:SENO) today announced that it ranked among the fastest growing companies in Deloitte's 2009 Technology Fast 500(TM), a ranking of the 500 fastest growing technology, media, telecommunications and life sciences and clean technology companies in North America. Rankings are based on percentage revenue growth during the five year period from 2004 to 2008. SenoRx grew 240 percent during this period, ranking it #460 of the list.
Source: Medical News (via PRIMEZONE) - October 21, 2009 Category: Pharmaceuticals Source Type: news
The Female Health Company Completes 150% Expansion of FC2 Manufacturing Capacity in MalaysiaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CHICAGO, Oct. 21, 2009 (GLOBE NEWSWIRE) -- The Female Health Company (Nasdaq:FHCO), which manufactures and markets the FC Female Condom(R) (FC1) and FC2 Female Condom(R) (FC2), today reported that it has completed the previously announced expansion of FC2 Female Condom(R) manufacturing capacity at its production facility in Malaysia.
Source: Medical News (via PRIMEZONE) - October 21, 2009 Category: Pharmaceuticals Source Type: news
ResCare's U.K. Subsidiary Awarded Flexible New Deal ContractsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LOUISVILLE, Ky., Oct. 21, 2009 (GLOBE NEWSWIRE) -- ResCare, Inc. (Nasdaq:RSCR), the nation's leading provider of residential, training, educational and support services for people with special needs, announced today that its subsidiary, PeopleServe, has been awarded five contracts by four prime contractors to operate job training and development programs serving adults in the United Kingdom. The prime contractors have agreements with the U.K. Department for Work and Pensions under its Flexible New Deal initiative to help the unemployed return to and remain in work. PeopleServe will provide workforce development services to...
Source: Medical News (via PRIMEZONE) - October 21, 2009 Category: Pharmaceuticals Source Type: news
Animal Health International, Inc. Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Conference Call InformationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WESTLAKE, Texas, Oct. 20, 2009 (GLOBE NEWSWIRE) -- Animal Health International, Inc. (Nasdaq:AHII) announced today that the Company will release financial results for its fiscal year 2010 first quarter ended September 30, 2009, on Tuesday, November 3, 2009. Animal Health International, Inc. will host a conference call the same day at 10:00 a.m. Eastern Standard Time to discuss these results and its business outlook.
Source: Medical News (via PRIMEZONE) - October 21, 2009 Category: Pharmaceuticals Source Type: news
ev3 Inc. to Report 2009 Third Quarter Results and Host Conference Call on October 27, 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PLYMOUTH, Minn., Oct. 20, 2009 (GLOBE NEWSWIRE) -- ev3 Inc. (Nasdaq:EVVV) will release its 2009 third quarter financial results on Tuesday, October 27, 2009, before regular market trading hours.
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
drugstore.com Reports Strong Revenue Growth and Record Gross Margins in the Third Quarter of 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BELLEVUE, Wash., Oct. 20, 2009 (GLOBE NEWSWIRE) -- drugstore.com, inc. (Nasdaq:DSCM), a leading online retailer of health, beauty, vision, and pharmacy products, today announced its financial results for the third quarter ended September 27, 2009. The company reported quarterly net sales of $96.8 million, driven by strong OTC and vision sales. Gross margins increased 70 basis points year-over-year to a record 29.3% and the company's net loss in its seasonally softest quarter was $1.6 million, an improvement of $2.0 million from the same period a year ago. The company reported adjusted EBITDA of $3.0 million which compared ...
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
Intuitive Surgical Announces Third Quarter EarningsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SUNNYVALE, Calif., Oct. 20, 2009 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), the industry leader in surgical robotics, today reported third quarter of 2009 revenue of $280.1 million, compared with $236.0 million for the third quarter of 2008. Third quarter of 2009 revenue included $6.3 million of revenue that was originally deferred in the first quarter of 2009 in association with discounted offers made to certain customers to upgrade da Vinci S Surgical Systems to our recently introduced da Vinci Si Surgical Systems. All da Vinci Si upgrades related to these offers have now been completed and the full $20....
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
Vascular Solutions Announces Third Quarter Results; Net Revenue Increases 11% to Record $17.2 Million; Net Income of $0.09 Per ShareEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MINNEAPOLIS, Oct. 20, 2009 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today reported financial results for the third quarter ended September 30, 2009. Highlights of the third quarter and other recent events include:
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
Generex: Going Concern QualificationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WORCESTER, Mass., Oct. 20, 2009 (GLOBE NEWSWIRE) -- Pursuant to Nasdaq Marketplace Rule 5250(b)(2), Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced that its consolidated financial statements for the fiscal year ended July 31, 2009 included in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on October 14, 2009 contained a going concern qualification from its independent registered public accounting firm. Nasdaq Marketplace Rule 5250(b)(2) requires separate public disclosure of a previously issued audit opinion that contains a going concern qualific...
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
ICU Medical, Inc. Increases Share Repurchase Authorization to $55 MillionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN CLEMENTE, Calif., Oct. 20, 2009 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leading low cost manufacturer of safe medical connectors, custom medical products and critical care devices, today announced that its Board of Directors has amended its previously announced stock repurchase program to permit share repurchases up to an aggregate of $55.0 million. The Company's stock repurchase program was originally adopted on July 18, 2008 and permitted repurchases up to $40.0 million.
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
Skylight Healthcare Systems Announces the Launch of iCareRounds(TM)Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN DIEGO, Oct. 20, 2009 (GLOBE NEWSWIRE) -- Skylight Healthcare Systems' 3rd Annual Client Conference served as the product launch venue for iCareRounds(TM) -- a full-featured video communications program that links hospital patients to connected members of their care team -- enabling virtual rounding right in the patient room at the push of a button. Engaging patients and families through a secure and private connection, iCareRounds allows all members of the care team to efficiently communicate and share relevant information with the patient from remote locations within or outside of the hospital.
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
Blue Frog Solutions Launches AFFIRM(TM) for Annuities Compliance and Order Management System Version 1.8Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
POMPANO BEACH, Fla., Oct. 20, 2009 (GLOBE NEWSWIRE) -- Blue Frog Solutions, a leading provider of Life & Annuity Order Management and Compliance Solutions, flawlessly launched AFFIRM for Annuities Compliance and Order Management System version 1.8 in August 2009.
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
CAS Medical Systems, Inc. Chosen by the Connecticut Technology Council as a Tech Top 40 Award WinnerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BRANFORD, Conn., Oct. 20, 2009 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM) today announced that it has been identified by the Connecticut Technology Council as a 2009 UHY LLP Tech Top 40 winner. This marks the eighth consecutive year that CASMED has been recognized by the Connecticut Technology Council as one of the fastest growing technology companies in the state based on percentage revenue growth over the past four years.
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
Myriad Pharmaceuticals Announces Presentation on Azixa(TM) at the 2009 Joint Meeting of the Society for Neuro-Oncology and the AANS/CNS Section on TumorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SALT LAKE CITY, Oct. 20, 2009 (GLOBE NEWSWIRE) -- Myriad Pharmaceuticals Inc. (Nasdaq:MYRX) today announced that an abstract has been selected for oral presentation at the 2009 Joint Meeting of the Society for Neuro-Oncology (SNO) and the AANS/CNS Section on Tumors being held October 22-24, 2009 in New Orleans, LA. The presentation will disclose new findings concerning Azixa(TM), a Myriad Pharmaceuticals drug candidate being developed as a treatment for recurrent glioblastoma multiforme (GBM) and metastatic melanoma. The SNO presentation will include data relating to the use of Azixa as a potential monotherapy and in poten...
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
Patient Access Solutions, Inc. Announces Appointment of Jeffrey T. Stern as Chief Financial OfficerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HAUPPAUGE, N.Y., Oct. 20, 2009 (GLOBE NEWSWIRE) -- Patient Access Solutions, Inc. (Pink Sheets: PASO), an emerging provider of healthcare/financial processing technologies that provide the healthcare industry a graceful migration to Electronic Medical Records (EMR), today announced the appointment of Jeffrey T. Stern as the Company's new Chief Financial Officer, effective immediately.
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
Harold C. Urschel, Jr., M.D. Joins Aastrom Biosciences' Board of DirectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ANN ARBOR, Mich., Oct. 20, 2009 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of autologous cell products for the treatment of chronic cardiovascular diseases, today announced that Harold C. Urschel, Jr., M.D., has been elected to the Company's Board of Directors.
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
Mymetics Corporation Presents Ground Breaking Results With Preventative HIV Vaccine at the World AIDS Vaccine Congress in Paris 19 - 22 OctoberEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
EPALINGES, Switzerland, Oct. 20, 2009 (GLOBE NEWSWIRE) -- Mymetics Corporation (OTCBB:MYMX), a pioneer in the development of mucosal focused vaccines for human infectious diseases, announced today that the company had been selected to present their ground breaking results obtained for their preventative HIV-1 vaccine.
Source: Medical News (via PRIMEZONE) - October 20, 2009 Category: Pharmaceuticals Source Type: news
MAKO Surgical Corp. Schedules Third Quarter 2009 Earnings Release and Conference Call for Tuesday, November 3, 2009Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
FT. LAUDERDALE, Fla., Oct. 19, 2009 (GLOBE NEWSWIRE) -- MAKO Surgical Corp. (Nasdaq:MAKO) announced today that it plans to release third quarter 2009 financial results after market close on Tuesday, November 3, 2009. Maurice R. Ferre, M.D., President and Chief Executive Officer, and Fritz L. LaPorte, Senior Vice President and Chief Financial Officer of MAKO, will host a conference call to review the third quarter 2009 results starting at 4:30 pm EST on the same day. The call will be concurrently webcast.
Source: Medical News (via PRIMEZONE) - October 19, 2009 Category: Pharmaceuticals Source Type: news
Northwestern University Study Finds Ultrasensitive Assay Can Predict Recurrence of Prostate CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
NORTHBROOK, Ill., Oct. 19, 2009 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced that a research team at Northwestern University's International Institute for Nanotechnology found that an ultrasensitive nanoparticle-based assay, 300 times more sensitive than commercial immunoassays, is capable of detecting previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.
Source: Medical News (via PRIMEZONE) - October 19, 2009 Category: Pharmaceuticals Source Type: news
Attacking Cancer With Specific Anti-Tumor PathwaysEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BEVERLY, Mass., Oct. 19, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX) today announced that data recently presented by the Company at the American Association for Cancer Research (AACR) along with other data developed by the Company indicate that Kevetrin is selectively targeting very specific anti-tumor pathways, such as AKT and p38 MAP kinase. The data presented at the AACR showed that Kevetrin was less cytotoxic than paclitaxel, cisplatin and 5FU while having better anti-tumor activity in two multi-drug resistant lung cancer cell lines. This indicates that Kevetrin is not acting primarily as a cytotoxic a...
Source: Medical News (via PRIMEZONE) - October 19, 2009 Category: Pharmaceuticals Source Type: news
LeMaitre Vascular, Inc. Schedules Third Quarter Results and Conference CallEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BURLINGTON, Mass., Oct. 19, 2009 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its 2009 third quarter financial results on October 28, 2009, after the close of the market. In conjunction with the release, a conference call will be hosted the same day at 5:00 PM ET. The call will be broadcast simultaneously over the internet.
Source: Medical News (via PRIMEZONE) - October 19, 2009 Category: Pharmaceuticals Source Type: news
Vital Images, Inc. to Webcast Third Quarter Earnings Conference Call Thursday, Nov. 5Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MINNEAPOLIS, Oct. 19, 2009 (GLOBE NEWSWIRE) -- Vital Images, Inc. (Nasdaq:VTAL), a leading provider of advanced visualization and analysis solutions, will host a live webcast of its third quarter conference call Thursday, Nov. 5, 2009, at 10:30 a.m. CT.
Source: Medical News (via PRIMEZONE) - October 19, 2009 Category: Pharmaceuticals Source Type: news
Scientific Industries Launches the Orbital-GenieEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BOHEMIA, N.Y., Oct. 19, 2009 (GLOBE NEWSWIRE) -- Scientific Industries Inc. (OTCBB:SCND), a leader in the design and production of shakers and vortex mixers, including the world-renowned Vortex-Genie, today announced the market launch of the new Orbital-Genie(TM). The Orbital-Genie is a heavy duty, large capacity orbital shaker designed to shake and mix, using an orbital motion, a variety of laboratory vessels such as flasks, bottles, and beakers.
Source: Medical News (via PRIMEZONE) - October 19, 2009 Category: Pharmaceuticals Source Type: news
Sales Focus Incorporated Expands Services Into the Medical Device Industry With the Hiring of Eric WiseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BALTIMORE, Oct. 19, 2009 (GLOBE NEWSWIRE) -- Sales Focus Incorporated, www.SalesFocusInc.com, the pioneer of the Sales Outsourcing industry, announced today they have officially brought in Eric Wise as their newest Senior Program Manager to oversee the Medical Device and Manufacturing division which will be based in Delaware.
Source: Medical News (via PRIMEZONE) - October 19, 2009 Category: Pharmaceuticals Source Type: news
Mauna Kea Technologies Announces Enrollment Completion of Two Multi-Center International GI Endoscopy Clinical Trials With CellvizioEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
PARIS, Oct. 19, 2009 (GLOBE NEWSWIRE) -- Mauna Kea Technologies announced today completion of enrollment for two company-sponsored multi-center international gastrointestinal (GI) endoscopy clinical trials using the Cellvizio(R) probe-based confocal laser endomicroscopy (pCLE) system. The "DONT BIOPCE study" and the "Cellvizio ERCP registry" were designed to evaluate if Cellvizio could improve diagnostic outcomes and biopsy efficiency in patients with Barrett's esophagus and those with suspected bile or pancreatic duct cancer, respectively. Both studies were initiated at the end of 2008 with groups of dedicated, world reno...
Source: Medical News (via PRIMEZONE) - October 19, 2009 Category: Pharmaceuticals Source Type: news
Immunomedics Awarded Three Grants by NIH to Develop New Agents for Imaging and Therapy of CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MORRIS PLAINS, N.J., Oct. 19, 2009 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (Nasdaq:IMMU), a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that it has been awarded 3 Small Business Innovation Research (SBIR) grants by the National Institutes of Health (NIH), totaling $2.1 million payable over a period of 2 years. One of the awards can be extended to 3 years with a potential $2.5 million additional funding, if certain goals and milestones are met.
Source: Medical News (via PRIMEZONE) - October 19, 2009 Category: Pharmaceuticals Source Type: news
PetMed Express D/B/A 1-800-PetMeds Announces Second Quarter Financial ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
POMPANO BEACH, Fla., Oct. 19, 2009 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (Nasdaq:PETS) today announced its financial results for the quarter ended September 30, 2009. Net income was $6.3 million, or $0.28 diluted per share, for the quarter ended September 30, 2009, compared to net income of $5.8 million, or $0.25 diluted per share, for the quarter ended September 30, 2008, a 12% increase to EPS. For the six months ended September 30, 2009, net income was $14.3 million or $0.63 diluted per share compared to net income of $12.4 million or $0.53 diluted per share for the six months ended September 30, 2008, an increase to ...
Source: Medical News (via PRIMEZONE) - October 19, 2009 Category: Pharmaceuticals Source Type: news
TRACON Announces CRADA With NCI to Study TRC105 in Prostate CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SAN DIEGO, Oct. 19, 2009 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and ophthalmology, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to collaborate on the study of TRC105 for the treatment of prostate cancer. TRC105 is TRACON's clinical stage monoclonal antibody that targets CD105, an endothelial cell membrane receptor that is essential for the process of new blood vessel formation called angiogenesis. Tumor growth and metastasis are dependent on angiogenesis, a...
Source: Medical News (via PRIMEZONE) - October 19, 2009 Category: Pharmaceuticals Source Type: news
DENTSPLY International Inc. to Present At the Northcoast Research Conference in New YorkEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
YORK, Pa., Oct. 16, 2009 (GLOBE NEWSWIRE) -- DENTSPLY International Inc. (Nasdaq:XRAY) today announced that Bill Jellison, Sr. Vice President and Chief Financial Officer, will be presenting at the Northcoast Research Conference in New York City on November 3, 2009.
Source: Medical News (via PRIMEZONE) - October 16, 2009 Category: Pharmaceuticals Source Type: news
Nanosphere, Inc. Prices Common Stock OfferingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
NORTHBROOK, Ill., Oct. 16, 2009 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced the pricing of its previously announced underwritten public offering of 4,700,000 shares of its common stock at a public offering price of $7.00 per share. In connection with the offering, the Company has also granted the underwriter a 30-day option to purchase up to an additional 705,000 shares of common stock to cover over-allotments, if any. Piper Jaffray & Co. acted as the sole manager for the offering.
Source: Medical News (via PRIMEZONE) - October 16, 2009 Category: Pharmaceuticals Source Type: news
Exiqon Launches New MicroRNA qPCR Expression PlatformEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
COPENHAGEN, Denmark, Oct. 15, 2009 (GLOBE NEWSWIRE) -- Exiqon A/S (Copenhagen:EXQ) today announced the global launch of its new platform for quantitative real-time PCR analysis of microRNAs. The new miRCURY LNA(TM) Universal RT microRNA PCR product line combines all the advantages of LNA(TM) technology with a Universal reverse transcription (RT) step, resulting in the most sensitive microRNA expression profiling system currently available.
Source: Medical News (via PRIMEZONE) - October 15, 2009 Category: Pharmaceuticals Source Type: news
Myriad Genetics Acquires Exclusive Rights to Pancreatic Cancer Gene Patents From Johns HopkinsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SALT LAKE CITY, Oct. 15, 2009 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced it has obtained from Johns Hopkins University a world-wide, exclusive license to patents covering mutations in the PALB2 gene that increase an individual's risk for developing pancreatic cancer later in life.
Source: Medical News (via PRIMEZONE) - October 15, 2009 Category: Pharmaceuticals Source Type: news
Questcor Resubmits Supplemental New Drug Application to FDA for H.P. Acthar(R) Gel for Treatment of Infantile SpasmsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
UNION CITY, Calif., Oct. 15, 2009 (GLOBE NEWSWIRE) -- Questcor Pharmaceuticals, Inc. (Nasdaq:QCOR) announced that it has resubmitted its filing to the U.S. Food & Drug Administration (FDA) for its supplemental New Drug Application (sNDA) seeking approval to market H.P. Acthar(R) Gel (repository corticotrophin injection) for the treatment of infantile spasms. The resubmission follows the FDA's request in May 2009 for the filing to include additional statistical analysis relating to data from one secondary study within the Company's filing.
Source: Medical News (via PRIMEZONE) - October 15, 2009 Category: Pharmaceuticals Source Type: news
Nanosphere, Inc. Announces Commencement of Public Offering of Common StockEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
NORTHBROOK, Ill., Oct. 15, 2009 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (the "Company") (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced that it intends to offer shares of its common stock in a public offering. Piper Jaffray & Co. is acting as the sole manager for the offering.
Source: Medical News (via PRIMEZONE) - October 15, 2009 Category: Pharmaceuticals Source Type: news
Nikon Instruments Unveils A1R-MP Multiphoton and Confocal Microscope SystemEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MELVILLE, N.Y., Oct. 15, 2009 (GLOBE NEWSWIRE) -- Nikon Instruments, Inc. (www.nikoninstruments.com) today unveiled its new A1R-MP Multiphoton and Confocal microscope system for high speed, high resolution and high sensitivity multiphoton excitation and confocal fluorescence imaging. The A1R-MP allows for imaging deeper, longer, sharper and brighter while remaining cell-friendly with fast resonant imaging at up to 420 fps.
Source: Medical News (via PRIMEZONE) - October 15, 2009 Category: Pharmaceuticals Source Type: news
Nikon Instruments Introduces CL-Quant Automated Image Analysis SoftwareEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
MELVILLE, N.Y., Oct. 15, 2009 (GLOBE NEWSWIRE) -- Nikon Instruments, Inc. (www.nikoninstruments.com) today introduced the new CL-Quant Automated Image Analysis Software featuring routines for assaying stem cell viability by label-free phase and fluorescence analysis. The software utilizes a unique set of preconfigured routines for standard assays and has a teachable interface for analysis creation and batch-processing for large time-lapse image data sets. The CL-Quant Automated Image Analysis Software is intended for use with Nikon's Biostation CT.
Source: Medical News (via PRIMEZONE) - October 15, 2009 Category: Pharmaceuticals Source Type: news
